Resistance of K-RasB(V12) proteins to farnesyltransferase inhibitors in Rat1 cells
Resistance of K-RasB(V12) proteins to farnesyltransferase inhibitors in Rat1 cells
复制标题
DOI:
10.1073/pnas.93.9.4454
复制
发表时间:
1996-04-30
影响因子:
11.1
通讯作者:
Brown, MS
中科院分区:
文献类型:
--
作者:
James, G;Goldstein, JL;Brown, MS
Benzodiazepine (BZA)-5B, a CAAX farnesyltransferase inhibitor, was previously shown to block the farnesylation of H-Ras and to reverse the transformed morphology of Rat1 cells expressing oncogenic H-Ras(V12). Nontransformed Rat1 cells were not affected by BW-SB, suggesting that they produce a form of Ras whose prenylation is not blocked by this compound. The likely candidate is K-RasB, which differs from H-Ras primarily in the terminal 24 amino acids. In the current study we examined the effect of BZA-5B on the prenylation of a chimeric oncogenic pas protein designated H/K-RasB(V12), consisting of the first 164 amino acids of H-Ras(V12) followed by the last 24 amino acids of K-RasB. BZA-5B failed to block the prenylation of this chimera and was thus unable to reverse the transformed morphology of Rat1 cells in which it was expressed. Another potent inhibitor of H-Ras farnesylation, L-739,749, also failed to block prenylation of H/K-RasB(V12), Similar results were obtained in transfected cells expressing a widely used version of K-RasB(V12) containing a 10-amino acid extension at its NH2 terminus. Neither BZA-5B nor L-739,749 reversed the transformed morphology of cells expressing H/K-RasB(V12). The resistance of K-RasB to farnesyltransferase inhibition provides a likely explanation for the resistance of nontransformed cells to the growth inhibitory effects of BZA-5B and L-739,749.